Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells.

Cohen NR, Brennan PJ, Shay T, Watts GF, Brigl M, Kang J, Brenner MB; ImmGen Project Consortium..

Nat Immunol. 2013 Jan;14(1):90-9. doi: 10.1038/ni.2490.

2.

Stages versus subsets: Invariant Natural Killer T cell lineage differentiation.

Buechel HM, Stradner MH, D'Cruz LM.

Cytokine. 2015 Apr;72(2):204-9. doi: 10.1016/j.cyto.2014.12.005. Review.

3.

Dicer-dependent microRNA pathway controls invariant NKT cell development.

Fedeli M, Napolitano A, Wong MP, Marcais A, de Lalla C, Colucci F, Merkenschlager M, Dellabona P, Casorati G.

J Immunol. 2009 Aug 15;183(4):2506-12. doi: 10.4049/jimmunol.0901361.

4.

Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.

Wu L, Gabriel CL, Parekh VV, Van Kaer L.

Tissue Antigens. 2009 Jun;73(6):535-45. doi: 10.1111/j.1399-0039.2009.01256.x. Review.

PMID:
19392798
5.

Essential role for autophagy during invariant NKT cell development.

Salio M, Puleston DJ, Mathan TS, Shepherd D, Stranks AJ, Adamopoulou E, Veerapen N, Besra GS, Hollander GA, Simon AK, Cerundolo V.

Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):E5678-87. doi: 10.1073/pnas.1413935112.

6.

The transcriptional programs of iNKT cells.

Kim EY, Lynch L, Brennan PJ, Cohen NR, Brenner MB.

Semin Immunol. 2015 Feb;27(1):26-32. doi: 10.1016/j.smim.2015.02.005. Review.

PMID:
25841627
7.

Transcriptional control of invariant NKT cell development.

Das R, Sant'Angelo DB, Nichols KE.

Immunol Rev. 2010 Nov;238(1):195-215. doi: 10.1111/j.1600-065X.2010.00962.x.

8.

Invariant natural killer T cells: bridging innate and adaptive immunity.

Van Kaer L, Parekh VV, Wu L.

Cell Tissue Res. 2011 Jan;343(1):43-55. doi: 10.1007/s00441-010-1023-3. Review.

9.

Cutting edge: the chemokine receptor CXCR3 retains invariant NK T cells in the thymus.

Drennan MB, Franki AS, Dewint P, Van Beneden K, Seeuws S, van de Pavert SA, Reilly EC, Verbruggen G, Lane TE, Mebius RE, Deforce D, Elewaut D.

J Immunol. 2009 Aug 15;183(4):2213-6. doi: 10.4049/jimmunol.0901213.

10.

Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.

Horst D, Geerdink RJ, Gram AM, Stoppelenburg AJ, Ressing ME.

Viruses. 2012 Oct 23;4(10):2379-99. doi: 10.3390/v4102379. Review.

11.

Activation and Function of iNKT and MAIT Cells.

Chandra S, Kronenberg M.

Adv Immunol. 2015;127:145-201. doi: 10.1016/bs.ai.2015.03.003. Review.

PMID:
26073984
12.

Critical role of TCR specificity in the development of Vγ1Vδ6.3+ innate NKTγδ cells.

Pereira P, Berthault C, Burlen-Defranoux O, Boucontet L.

J Immunol. 2013 Aug 15;191(4):1716-23. doi: 10.4049/jimmunol.1203168.

13.

Development of invariant natural killer T cells.

Gapin L.

Curr Opin Immunol. 2016 Apr;39:68-74. doi: 10.1016/j.coi.2016.01.001. Review.

PMID:
26802287
14.

KLRG+ invariant natural killer T cells are long-lived effectors.

Shimizu K, Sato Y, Shinga J, Watanabe T, Endo T, Asakura M, Yamasaki S, Kawahara K, Kinjo Y, Kitamura H, Watarai H, Ishii Y, Tsuji M, Taniguchi M, Ohara O, Fujii S.

Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12474-9. doi: 10.1073/pnas.1406240111.

15.

Invariant natural killer T cell-based immunotherapy for cancer.

Motohashi S, Nakayama T.

Immunotherapy. 2009 Jan;1(1):73-82. doi: 10.2217/1750743X.1.1.73. Review.

PMID:
20635975
16.

From the Deep Sea to Everywhere: Environmental Antigens for iNKT Cells.

Wingender G.

Arch Immunol Ther Exp (Warsz). 2016 Aug;64(4):291-8. doi: 10.1007/s00005-015-0381-7. Review.

PMID:
26703211
17.

MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development.

Sandrock I, Ziętara N, Łyszkiewicz M, Oberdörfer L, Witzlau K, Krueger A, Prinz I.

PLoS One. 2015 Dec 16;10(12):e0145010. doi: 10.1371/journal.pone.0145010.

18.

Invariant NKT cells inhibit development of the Th17 lineage.

Mars LT, Araujo L, Kerschen P, Diem S, Bourgeois E, Van LP, Carrié N, Dy M, Liblau RS, Herbelin A.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6238-43. doi: 10.1073/pnas.0809317106.

19.

Making memory at birth: understanding the differentiation of natural killer T cells.

Engel I, Kronenberg M.

Curr Opin Immunol. 2012 Apr;24(2):184-90. doi: 10.1016/j.coi.2012.01.012. Review.

20.

Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cells.

O'Reilly V, Zeng SG, Bricard G, Atzberger A, Hogan AE, Jackson J, Feighery C, Porcelli SA, Doherty DG.

PLoS One. 2011;6(12):e28648. doi: 10.1371/journal.pone.0028648.

Items per page

Supplemental Content

Support Center